RxY

RxY is a global healthcare research agency that helps pharmaceutical organizations understand the reasons behind physicians’ prescribing decisions. Rather than reporting only what was prescribed, RxY investigates why physicians chose a therapy, revealing decision drivers, barriers, and competitive dynamics. Its AI-powered research uses conversational physician interviews conducted within 24–48 hours of consultations, supported by data from 150–210 specialists and 500–1,500 patient charts per research wave.

RxY provides market research and strategic insight across a range of dynamic therapeutic areas, including dermatology, cardiometabolic disease, rheumatology, neurology, blood cancers, gastroenterology, and solid tumours. Its work supports commercial teams with launch planning, brand strategy, forecasting, messaging, and lifecycle management. Clients can draw on therapeutic-area expertise, scientific research design, expert guidance, and interactive dashboards to turn complex findings into actionable decisions.

The agency partners with pharmaceutical organizations internationally, with offices across North America, Europe, Africa, and Asia-Pacific. RxY also shares research findings, expert perspectives, and industry trends through its Hot Topics articles, and offers opportunities to join its collaborative team.